3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Prostatic Neoplasms
1
Premature Birth
1
Patient Compliance
1
Pain
1
Hirschsprung Disease
1
Heart Defects, Congenital
1
Head and Neck Neoplasms
1
Fatigue
1
Depression
1
Congenital Abnormalities
1
Child Nutrition Disorders
1
Burnout, Psychological
1
Burnout, Professional
1
Anxiety Disorders
1
Acquired Immunodeficiency Syndrome
1
Interventions
fludarabine phosphate
13
Peripheral Blood Stem Cell Transplantation
12
Cyclophosphamide
12
Cyclosporine
11
Busulfan
9
Mycophenolic Acid
8
Filgrastim
8
Antilymphocyte Serum
8
Whole-Body Irradiation
7
Radiotherapy
5
Methotrexate
5
Methylprednisolone
4
Melphalan
4
Cord Blood Stem Cell Transplantation
4
Tacrolimus
3
Cytarabine
3
Psychiatric Rehabilitation
2
Granulocyte Colony-Stimulating Factor
2
Flow Cytometry
2
Etoposide
2
Early Intervention, Educational
2
Dexamethasone
2
Calcium Dobesilate
2
Aprepitant
2
thymoglobulin
1
sargramostim
1
plerixafor
1
merphos
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Congenital Abnormalities
×
Self Care
×
Clear all
NCT04150120
2026-04-06
eChildHealth
Lund University
Phase NA
Completed
720 enrolled